Figure 17 displays a forest plot for the network meta-analysis of studies reporting ACR50 response rates. Two comparisons were used in this analysis. Study-level data used in this Figure are presented in Appendix C. This figure is described further in the KQ1 Results section “Non-TNF Versus Non-TNF” as follows: “In NWMA of ACR50 response and radiographic progression, comparisons of TCZ (with or without MTX) versus ABA (with or without MTX) found no significant differences between groups”.

Figure 17Forest plot for network meta-analysis of ACR50 response rates: Non-TNF biologic versus non-TNF biologic

95% CI = 95% confidence interval; ACR50 = American College of Rheumatology 50% improvement; MTX = methotrexate; RR = relative risk; v TNF = tumor necrosis factor; s. = versus.

From: Results

Cover of Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update
Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 211.
Donahue KE, Gartlehner G, Schulman ER, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.